Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AMGN | GILD | VRTX | BIIB |
| Company | Alnylam Pharmaceuticals | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 276.53 | 337.03 | 84.39 | 477.70 | 200.57 |
| High | 279.85 | 338.70 | 84.65 | 483.98 | 204.18 |
| Low | 273.53 | 334.61 | 83.43 | 476.27 | 200.11 |
| Last | 276.33 | 335.95 | 83.90 | 477.90 | 201.44 |
| Change | +3.18 | +3.03 | +0.01 | +3.74 | +3.85 |
| % Change | +1.16% | +0.91% | +0.01% | +0.79% | +1.95% |
| Volume | 603,867 | 1,626,112 | 8,797,631 | 939,784 | 1,122,166 |
| 20-Day Average Volume | 906,508 | 1,760,681 | 6,694,901 | 987,024 | 828,423 |
| Previous Close | 273.15 | 332.92 | 83.89 | 474.16 | 197.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 266.38 | 329.59 | 80.07 | 479.86 | 201.60 |
| 20-Day Raw Stochastic | 73.71% | 84.75% | 89.62% | 43.50% | 63.34% |
| 20-Day Relative Strength | 59.86% | 57.67% | 71.87% | 49.36% | 45.22% |
| Weighted Alpha | +43.78 | +27.09 | +18.24 | +33.54 | -21.62 |
| Today's Opinion | 96% Buy | 96% Buy | 88% Buy | 40% Buy | 100% Sell |
| Previous Opinion | 96% Buy | 88% Buy | 88% Buy | 40% Buy | 100% Sell |
| Last Month's Opinion | 100% Buy | 88% Buy | 56% Buy | 88% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.58% since 09/12/24 | +1.78% since 09/12/24 | +0.89% since 09/12/24 | -0.16% since 09/12/24 | +1.79% since 09/12/24 |
| Low | 259.01 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 | 192.25 on 09/13/24 |
| High | 279.85 on 09/19/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 490.15 on 09/16/24 | 204.18 on 09/19/24 |
| 1-Month | |||||
| %Chg | +0.67% since 08/19/24 | +2.43% since 08/19/24 | +12.69% since 08/19/24 | -2.08% since 08/19/24 | -2.24% since 08/19/24 |
| Low | 244.88 on 09/06/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 | 192.25 on 09/13/24 |
| High | 287.55 on 08/29/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +79.60% since 06/18/24 | +9.79% since 06/18/24 | +32.86% since 06/18/24 | +2.27% since 06/18/24 | -9.93% since 06/18/24 |
| Low | 153.23 on 06/20/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 192.25 on 09/13/24 |
| High | 287.55 on 08/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | +86.50% since 03/19/24 | +23.63% since 03/19/24 | +14.29% since 03/19/24 | +15.10% since 03/19/24 | -7.86% since 03/19/24 |
| Low | 141.98 on 04/25/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 287.55 on 08/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,551,284 | 178,589,936 | 104,514,608 | 122,358,416 | 28,768,510 |
| Shares Outstanding, K | 126,492 | 536,435 | 1,245,853 | 258,053 | 145,597 |
| Annual Sales | 1,828,290,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -440,240,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 659,830,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 2,464,900,000 |
| Last Quarter Net Income | -16,890,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 583,600,000 |
| 60-Month Beta | 0.38 | 0.61 | 0.18 | 0.40 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.56 on 08/01/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 11/07/24 | 10/29/24 | 11/05/24 | 11/04/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 17.67 | 0.00 | 12.19 |